Galectin-3 and histological, molecular and biochemical aspects of myocardial fibrosis in heart failure of hypertensive origin (Q57395332)

0 references

Elena Zubillaga

0 references

Mariano Larman

0 references

Javier Díez

European Journal of Heart Failure

0 references

publication date

11 February 2015

0 references

published in

0 references

volume

0 references

issue

0 references

page(s)

385-392

0 references

cites work

The regulation of inflammation by galectin-3.

1 reference

Galectin-3 marks activated macrophages in failure-prone hypertrophied hearts and contributes to cardiac dysfunction

21 January 2018

1 reference

Novel anti-inflammatory mechanisms of N-Acetyl-Ser-Asp-Lys-Pro in hypertension-induced target organ damage.

21 January 2018

1 reference

Genetic and pharmacological inhibition of galectin-3 prevents cardiac remodeling by interfering with myocardial fibrogenesis

21 January 2018

1 reference

N-acetyl-seryl-aspartyl-lysyl-proline prevents cardiac remodeling and dysfunction induced by galectin-3, a mammalian adhesion/growth-regulatory lectin

21 January 2018

1 reference

Aldosterone inhibits antifibrotic factors in mouse hypertensive heart

21 January 2018

1 reference

DIOL triterpenes block profibrotic effects of angiotensin II and protect from cardiac hypertrophy

21 January 2018

1 reference

Galectin-3 in ambulatory patients with heart failure: results from the HF-ACTION study

21 January 2018

1 reference

Prognostic value of galectin-3, a novel marker of fibrosis, in patients with chronic heart failure: data from the DEAL-HF study

21 January 2018

1 reference

Galectin-3: a modifiable risk factor in heart failure

21 January 2018

1 reference

Galectin-3 increase in endurance athletes

21 January 2018

1 reference

How to diagnose diastolic heart failure: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and Echocardiography Associations of the European Society of Cardiology

21 January 2018

1 reference

Local expression of myocardial galectin-3 does not correlate with its serum levels in patients undergoing heart transplantation

21 January 2018

1 reference

Aldosterone induced galectin-3 secretion in vitro and in vivo: from cells to humans

21 January 2018

1 reference

The impact of galectin-3 inhibition on aldosterone-induced cardiac and renal injuries.

21 January 2018

1 reference

The galectin profile of the endothelium: altered expression and localization in activated and tumor endothelial cells.

21 January 2018

1 reference

Coronary sinus biomarker sampling compared to peripheral venous blood for predicting outcomes in patients with severe heart failure undergoing cardiac resynchronization therapy: the BIOCRT study

21 January 2018

1 reference

New targets to treat the structural remodeling of the myocardium

21 January 2018

1 reference

Galectin-3: an open-ended story

21 January 2018

1 reference

Systemic inflammation in heart failure--the whys and wherefores

21 January 2018

1 reference

Positioning of inflammatory biomarkers in the heart failure landscape

21 January 2018

1 reference

The relationship between serum galectin-3 and serum markers of cardiac extracellular matrix turnover in heart failure patients.

21 January 2018

1 reference

Comparison the prognostic value of galectin-3 and serum markers of cardiac extracellular matrix turnover in patients with chronic systolic heart failure

21 January 2018

1 reference

Increased collagen type I synthesis in patients with heart failure of hypertensive origin: relation to myocardial fibrosis

21 January 2018

1 reference

Collagen cross-linking but not collagen amount associates with elevated filling pressures in hypertensive patients with stage C heart failure: potential role of lysyl oxidase

21 January 2018

1 reference

Alterations in the pattern of collagen deposition may contribute to the deterioration of systolic function in hypertensive patients with heart failure

21 January 2018

1 reference

ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult: executive summary

21 January 2018

1 reference

Galectin-3 Mediates Aldosterone-Induced Vascular Fibrosis

21 January 2018

1 reference

inferred from DOI database lookup

7 January 2021

based on heuristic

Measuring extracellular matrix turnover in the serum of patients with idiopathic or ischemic dilated cardiomyopathy and impact on diagnosis and prognosis

1 reference

inferred from DOI database lookup

7 January 2021

based on heuristic

Evaluating the utility of circulating biomarkers of collagen synthesis in hypertrophic cardiomyopathy

1 reference